Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Markus Neurath and Raja Atreya.
Markus Neurath
Connection Strength
0.511
Raja Atreya
  1. Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes? Visc Med. 2020 Aug; 36(4):338-342.
    View in: PubMed
    Score: 0.221
  2. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis. 2021 10; 80(10):1339-1344.
    View in: PubMed
    Score: 0.059
  3. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2021 10; 80(10):1312-1316.
    View in: PubMed
    Score: 0.059
  4. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. J Crohns Colitis. 2021 May 04; 15(5):864-868.
    View in: PubMed
    Score: 0.059
  5. Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling. Gastroenterology. 2021 02; 160(3):925-928.e4.
    View in: PubMed
    Score: 0.057
  6. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.